Exchange: NASDAQ·Updated 03:12 PM EDT

TEM News

News
all
press releases
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Tempus AI, Inc. (NASDAQ: TEM) today announced that Founder and CEO Eric Lefkofsky will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 8:30 a.m. ET in New York City.A live audio webcast of the conversation will be...
Business Wire
More News
Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?
Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 PR Newswire AUSTIN, Texas, Sept. 3, 2026 AUSTIN, Texas, Sept. 3, 2026 /PRNewswire/ -- Equity Insider News Commentary - Pharmaceutical research is being rebuilt...
PR Newswire
Tempus AI's Data Business Is Priced Like a Vendor, Not a Platform, Analyst Says
Tempus AI receives an Overweight rating and $80 price target from Cantor Fitzgerald, which sees significant upside from its data and applications business.read more...
Benzinga
Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Tempus AI Director Nadja West Sells 3,000 Shares for $207,000
Key PointsThe disposition involved 3,000 shares executed at $69.00 per share, totaling $207,000 in transaction value on August 28, 2026...
Nasdaq News: Markets
Cathie Wood Sells $15.6 Million of Tempus AI Stock After Merck-Moderna Trial Win, Ark Keeps Selling AMD Shares
Ark Invest sold $15.6 million of Tempus AI and $3.4 million of AMD on Tuesday, Sept. 1, 2026.read more...
Benzinga
Noteworthy Friday Option Activity: TEM, MRNA, MARA
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Tempus AI Inc (Symbol: TEM), where a total of 41,848 contracts have traded so far, representing approximately 4.2 million underlying shares. That amounts to about 57.1...
Nasdaq News: Markets
SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future
ARK sees a path toward custom cancer treatments for every patient, though current costs of $200,000-$300,000 remain a major hurdle.
Stocktwits
Cathie Wood Loads Up on Cerebras Systems Stock as AI Chip Race With Nvidia Heats Up Ark Keeps on Dumping AMD Shares
Ark Invest bought roughly $17 million in Cerebras shares Tuesday, Aug. 25, 2026, while trimming its Tempus AI and AMD positionsread more...
Benzinga

Advertisement|Remove ads.